Xiao et al reported that targeting Epstein–Barr virus oncoprotein latent membrane protein 1 (LMP1)-mediated-glycolysis and -HK2 sensitizes nasopharyngeal carcinoma to radiation therapy [43]. Here, PDLIM7 is linked to nasopharyngeal carcinoma.